1. Home
  2. SGMO vs MLGO Comparison

SGMO vs MLGO Comparison

Compare SGMO & MLGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGMO
  • MLGO
  • Stock Information
  • Founded
  • SGMO 1995
  • MLGO 2018
  • Country
  • SGMO United States
  • MLGO China
  • Employees
  • SGMO N/A
  • MLGO N/A
  • Industry
  • SGMO Biotechnology: Biological Products (No Diagnostic Substances)
  • MLGO EDP Services
  • Sector
  • SGMO Health Care
  • MLGO Technology
  • Exchange
  • SGMO Nasdaq
  • MLGO Nasdaq
  • Market Cap
  • SGMO 122.8M
  • MLGO 104.2M
  • IPO Year
  • SGMO 2000
  • MLGO N/A
  • Fundamental
  • Price
  • SGMO $0.64
  • MLGO $9.50
  • Analyst Decision
  • SGMO Strong Buy
  • MLGO
  • Analyst Count
  • SGMO 7
  • MLGO 0
  • Target Price
  • SGMO $5.29
  • MLGO N/A
  • AVG Volume (30 Days)
  • SGMO 4.9M
  • MLGO 269.2K
  • Earning Date
  • SGMO 11-11-2025
  • MLGO 12-16-2025
  • Dividend Yield
  • SGMO N/A
  • MLGO N/A
  • EPS Growth
  • SGMO N/A
  • MLGO N/A
  • EPS
  • SGMO N/A
  • MLGO 4.04
  • Revenue
  • SGMO $81,706,000.00
  • MLGO $61,302,336.00
  • Revenue This Year
  • SGMO $28.47
  • MLGO N/A
  • Revenue Next Year
  • SGMO N/A
  • MLGO N/A
  • P/E Ratio
  • SGMO N/A
  • MLGO $2.32
  • Revenue Growth
  • SGMO 565.52
  • MLGO N/A
  • 52 Week Low
  • SGMO $0.41
  • MLGO $7.82
  • 52 Week High
  • SGMO $3.18
  • MLGO $972.00
  • Technical
  • Relative Strength Index (RSI)
  • SGMO 49.82
  • MLGO 46.10
  • Support Level
  • SGMO $0.62
  • MLGO $8.67
  • Resistance Level
  • SGMO $0.69
  • MLGO $9.74
  • Average True Range (ATR)
  • SGMO 0.05
  • MLGO 0.66
  • MACD
  • SGMO -0.01
  • MLGO -0.14
  • Stochastic Oscillator
  • SGMO 25.77
  • MLGO 23.97

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

About MLGO MicroAlgo Inc.

MicroAlgo Inc is divided into two segments: Central processing algorithm services & Intelligent chips and services. The majority is from the Central Processing Algorithm Services. which refers to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.

Share on Social Networks: